Note: Ingredients listed on restricted chemical lists
EC/CAS
204-881-4/128-37-0
Name of the chemical
2,6-di-tert-butyl-p-cresol
Concentration
>=0.25-<2.5
General Information
Version
2.02
Revision date
2015-01-28
Product name
Aral Vitam DE 32
supplier name
BP France
Emergency telephone
01 45 42 59 59, +44 (0) 1235 239 670
Icons in SDS
Company Information
company name
BP France
e-mail address of the competent person responsible for the Safety Data Sheet
MSDSadvice@bp.com
GHS Information
Signal word
No signal word
Hazard Codes
Hazard statements (CLP)
H412
Hazard statements
Code
Statements
H412
Harmful to aquatic life with long lasting effects
Section 2
SECTION 2: Hazards identification
Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS]]
Product definition
Mixture
2.1 Classification of the substance or mixture
R52/53
Environmental hazards
Harmful to aquatic organisms, may cause long-term adverse effects in the aquatic environment. See Section 16 for the full text of the R phrases or H statements declared above. See sections 11 and 12 for more detailed information on health effects and symptoms and environmental hazards.
Signal word
No signal word.
Hazard statements
H412 - Harmful to aquatic life with long lasting effects.
Prevention
P273 - Avoid release to the environment.
Response
Not applicable.
Storage
Not applicable.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Contains
Reaction products of bis(4-methylpentan-2-yl)dithiophosphoric acid with phosphorus elements oxide, propylene oxide and amines, C12-14-alkyl (branched). May produce an allergic reaction.
Special packaging requirements
Containers to be fitted Not applicable. with child-resistant fastenings
Tactile warning of danger
Not applicable.
Other hazards which do not result in classification
Defatting to the skin. Note: High Pressure Applications Injections through the skin resulting from contact with the product at high pressure constitute a major medical emergency. See 'Notes to physician' under First-Aid Measures, Section 4 of this Safety Data Sheet.
